CIK 0000025743
- Non-accelerated filer
- Smaller reporting company
TherapeuticsMD, Inc.
Sign in to watch- Ticker
- TXMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 870233535
- Phone
- +1 561-961-1900
- Business address
- 951 YAMATO ROAD, SUITE 220, BOCA RATON, FL, 33431
- Former names
- AMHN, Inc., CROFF ENTERPRISES INC, CROFF OIL CO
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-11-28 | Milligan John C.K. IV President/Secretary | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −129,000 | 645,255 | ||
| 2018-11-27 | Finizio Robert G CEO | Exercise or conversion | +92,000 | $0.10 | $9K | 18,485,559 |
| 2018-11-27 | Finizio Robert G CEO | Sale | −92,000 | $4.81 | $442K | 18,393,559 |
| 2018-11-27 | Finizio Robert G CEO | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −92,000 | 368,910 | ||
| 2018-11-26 | Finizio Robert G CEO | Exercise or conversion | +92,000 | $0.10 | $9K | 18,485,559 |
| 2018-11-26 | Finizio Robert G CEO | Sale | −92,000 | $4.86 | $447K | 18,393,559 |
| 2018-11-26 | Finizio Robert G CEO | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −92,000 | 460,910 | ||
| 2018-11-20 | Bernick Brian Director | Exercise or conversion | +91,400 | $0.10 | $9K | 6,648,771 |
| 2018-11-20 | Bernick Brian Director | Sale | −91,400 | $4.74 | $433K | 6,557,371 |
| 2018-11-20 | Bernick Brian Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −91,400 | 366,110 | ||
| 2018-11-19 | Bernick Brian Director | Exercise or conversion | +91,400 | $0.10 | $9K | 6,648,771 |
| 2018-11-19 | Bernick Brian Director | Sale | −91,400 | $4.75 | $434K | 6,557,371 |
| 2018-11-19 | Bernick Brian Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −91,400 | 457,510 | ||
| 2018-11-15 | Milligan John C.K. IV President/Secretary | Exercise or conversion | +129,000 | $0.10 | $13K | 1,601,419 |
| 2018-11-15 | Milligan John C.K. IV President/Secretary | Sale | −129,000 | $4.99 | $644K | 1,472,419 |
| 2018-11-15 | Milligan John C.K. IV President/Secretary | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −129,000 | 774,255 | ||
| 2018-11-14 | Milligan John C.K. IV President/Secretary | Exercise or conversion | +129,000 | $0.10 | $13K | 1,601,419 |
| 2018-11-14 | Milligan John C.K. IV President/Secretary | Sale | −129,000 | $4.82 | $622K | 1,472,419 |
| 2018-11-14 | Milligan John C.K. IV President/Secretary | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −129,000 | 903,255 | ||
| 2018-11-13 | Finizio Robert G CEO | Exercise or conversion | +92,000 | $0.10 | $9K | 18,485,559 |
Page 18 of 24 · 463 trades